Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
55%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
THNR
19
HOLDINGS
67%
ALSO IN OZEM
OZEM
21
HOLDINGS
60%
ALSO IN THNR
SECTOR DRIFT (THNR minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
NOVO-NORDISK A/S-SPONS ADR | 9.1% | 12.0% | 9.1% |
 |
ELI LILLY & CO | 8.9% | 12.1% | 8.9% |
 |
CHINA PHARMACEUTICAL GROUP | 5.4% | 6.4% | 5.4% |
|
PFIZER INC | 4.7% | 6.9% | 4.7% |
|
VIKING THERAPEUTICS, INC. | 4.5% | 4.8% | 4.5% |
THNR Overweight Relative to OZEM
|
REGENERON PHARMACEUTICALS | 6.1% |
|
SCHOLAR ROCK HOLDING CORP. | 5.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 5.3% |
|
MERCK & CO. INC. | 5.1% |
|
ABBVIE INC | 5.0% |
|
HIMS & HERS HEALTH, INC. CLASS A | 4.4% |
 |
INNOVENT BIOLOGICS, INC. | 3.1% |
|
AMGEN INC | 1.2% |
 |
ASTRAZENECA PLC | 0.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 0.1% |
THNR Underweight Relative to OZEM
 |
ASCLETIS PHARMA, INC. | -4.0% |
|
MBX BIOSCIENCES INC | -3.4% |
|
ELI LILLY & CO | -3.2% |
|
NOVO-NORDISK A/S-SPONS ADR | -2.9% |
|
HANSOH PHARMACEUTICAL GROUP COMPANY | -2.8% |
|
THE UNITED LABORATORIES INTE | -2.6% |
|
PFIZER INC | -2.1% |
|
GILEAD SCIENCES INC | -1.8% |
|
RHYTHM PHARMACEUTICALS, INC. | -1.6% |
 |
HANMI PHARM CO LTD | -1.6% |